J. Zhu et al. / Tetrahedron Letters 47 (2006) 7267–7270
7269
Table 1 (continued)
Entry
Amine R1NH2
Aldehyde R2CHO
Boronic acid R3B(OH)2
Purity of 15a (%)
Yieldb (%)
86
H2N
H2N
N
B(OH)2
CHO
S
8
100
HO
B(OH)2
N
N
N
CHO
CHO
9
96
85
80c
MeO
HO
N
H2N
H2N
N
N
B(OH)2
B(OH)2
10
11
96
91
67
66
CHO
MeO
N
NC
a Determined by LC–MS with both UV and ELSD detectors; further confirmed with 1H NMR analysis.
b Determined by weight of the crude products based on the loading of the resins.
c Isolated yield.
Shapiro, S.; McBriar, M. D.; Clader, J. W.; Greenlee, W. J.;
Spar, B.; Kowalski, T. J.; Farley, C.; Cook, J.; Heek, M. V.;
Weig, B.; O’Neil, K.; Graziano, M.; Hawes, B. J. Med.
Chem. 2005, 48, 4746.
purity. In addition, the purity of the final products
appeared to be better when dioxane was used as the
solvent rather than with DMF or THF. Cleavage with
10% TFA in DCM afforded the desired product 15.
3. Yang, B. H.; Buchwald, S. L. J. Organomet. Chem. 1999,
576, 125.
As shown in Table 1, a variety of amines were examined.
Some amines led to a low yield of the final products,
though the purity was found to be satisfactory (entries
1 and 2).8 Heterocyclic aldehydes were incorporated to
further increase structural diversity. Examples include
thiophenyl, furanyl, and pyridinyl groups (entries 1, 2,
and 3). Both electron-donating groups and electron-
withdrawing groups on the aryl moiety of boronic acids
led to the expected products in good purity. Functional
groups such as alcohols, phenols, cyano, and carbonyl
groups are tolerated in the final coupling reaction
(entries 2, 5, 9, and 11).
4. Yang, L.; Morriello, G.; Prendergast, K.; Cheng, K.; Jacks,
T.; Chan, W. W.; Schleim, K. D.; Smith, R. G.; Patchett, A.
A. Bioorg. Med. Chem. Lett. 1998, 8, 107.
5. Burkholder, T. P.; Kudlaca, E. M.; Maynard, G. D.; Liu,
X.; Le, T.; Webster, M. E.; Horgan, S. W.; Wenstrup, D.
L.; Freund, D. W.; Boyer, F.; Bratton, L.; Gross, R. S.;
Knippenberg, R. W.; Logan, D. E.; Jones, B. J.; Chen, T.;
Geary, J. L.; Correll, M. A.; Poole, J. C.; Mandagere, A.
K.; Thompson, T. N.; Hwang, K. Bioorg. Med. Chem. Lett.
1997, 7, 2531.
6. (a) Bork, J. T.; Lee, J. W.; Khersonsky, S. M.; Moon, H.;
Chang, Y. Org. Lett. 2003, 5, 117; (b) Ashley-Fenwick, A.
E.; Garnier, B.; Gribble, A. D.; Ife, R. J.; Rawlings, A. D.;
Witherington, J. Bioorg. Med. Chem. Lett. 2001, 11, 195.
7. Abdel-Magid, A. F.; Carson, K. G.; Harris, B. D.;
Maryanoff, C. A.; Shah, R. J. Org. Chem. 1996, 61, 3849.
8. Analytical data for selected compounds. Compound 15-1:
1H NMR (400 MHz, CDCl3): d 7.60–6.88 (m, 10H), 4.28 (s,
2H), 4.26 (s, 2H), 4.21 (s, 1H), 3.61–3.44 (m, 4H), 3.15–2.82
(m, 4H), 2.68 (s, 3H), 2.58 (s, 3H), 2.40–2.16 (m, 6H); MS
(ELS): 506.2 (M+H+). Compound 15-2: 1H NMR
(400 MHz, CDCl3): d 7.79–7.38 (m, 9H), 6.02–5.98 (m,
1H), 4.12 (s, 1H), 3.80–3.62 (m, 4H), 3.18–2.80 (m, 2H),
2.76 (s, 3H), 2.58 (s, 3H), 2.24 (s, 3H), 2.25–1.90 (m, 8H);
MS (ELS): 471.6 (M+H+). Compound 15-3: 1H NMR
(400 MHz, CDCl3): d 7.78–6.75 (m, 14H), 4.92 (bs, 1H),
4.32 (s, 4H), 4.28 (s, 2H), 3.78 (s, 3H), 3.42 (br s, 2H), 2.59
(s, 3H), 2.58–2.42 (m, 8H); MS (ELS): 564.7 (M+H+).
9. Typical procedures. Attachment of amines to solid support:
To a suspension of FDMP (2-(3,5-dimethoxy-4-formyl-
phenoxy)ethoxymethyl) resin (1.5 mmol/g) in 2% acetic
acid in DCE was added the amine (6 equiv, 0.4 M). The
reaction mixture was shaken for 2 h, followed with the
addition of NaBH(OAc)3 (10 equiv). The mixture was
shaken overnight at room temperature. After quenching the
excess of NaBH(OAc)3 with methanol, the resin was
washed with MeOH, DCM, then DMF (2·), MeOH, and
DCM successively, and then dried in vacuo overnight.
In conclusion, an efficient solid-phase synthesis of bi-
aryl-piperidines has been developed.9 The immobilized
bromo-aryl scaffold could allow not only for manipula-
tion of the nitrogen, but also incorporation of various
groups on the aryl moiety.
Acknowledgments
The authors would like to thank Mr. George Elgar for
providing analytical support.
References and notes
1. (a) Bondensgaard, K.; Ankerson, M.; Thogersen, H.;
Hansen, B. S.; Wulff, B. S.; Bywater, R. P. J. Med. Chem.
2004, 47, 888–899; (b) Bemis, G. W.; Murcko, M. A. J.
Med. Chem. 1996, 39, 2887.
2. (a) Brown, G. R.; Clarke, D. S.; Foubister, A. J.; Freeman,
S.; Harrison, P. J.; Johnson, M. C.; Mallion, K. B.;
McCormick, J.; McTaggart, F.; Reid, A. C.; Smith, G. J.;
Taylor, M. J. J. Med. Chem. 1996, 39, 2971; (b) Palani, A.;